(Q42236968)
Statements
Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study* (English)
Gordon R Bernard
R Phillip Dellinger
James A Russell
Steven P Larosa
Pierre-Francois Laterre
Mitchell M Levy
Wayne Dankner
Nicola Schmitt
Xavier Wittebole